Condition: Failed Back Surgery Syndrome (FBSS) · Persistent Spinal Pain Syndrome Type 2 (PSPS-T) Lower Spine · Neurophysiological Sensitivity to Spinal Cord Stimulation · Sponsor: Brai²n
This pilot study investigates the effects of reducing pain medication including opioids and anticonvulsants, on spinal cord sensitivity during closed-loop spinal cord stimulation (SCS). Patients with Persistent Spinal Pain Syndrome Type 2 (FBSS/FNSS) will undergo a standard 21-day SCS trial with the Evoke closed-loop system, followed by permanent implantation if successful. Neurophysiological responses (activation plots, conduction velocity, chronaxie, rheobase) and patient-reported outcomes (VAS, activity, sleep, medication intake) will be collected during the trial and up to 6 months after implantation. The goal is to evaluate the relationship between medication tapering and spinal cord sensitivity
This description comes directly from the study's public registry record.
Pieter Van Looy · +32 3 443 48 72 · pieter.vanlooy@zas.be
Always discuss trial participation with your own doctor first.
| Brai²n - ZAS Augustinus | Wilrijk, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07502612